Immersive virtual reality and antigravity treadmill training for gait rehabilitation in Parkinson’s disease: A pilot and feasibility study

Brandín-De la Cruz, N. ; Secorro, N. ; Calvo, S. ; Benyoucef, Y. ; Herrero, P. (Universidad de Zaragoza) ; Bellosta-López, P.

Resumen: Introduction. Treadmill training is considered an effective intervention to improve gait ability in patients with Parkinson’s disease (PD). In parallel, virtual reality shows promising intervention with several applications in the inpatient medical setting.
Aim. To evaluate the feasibility and preliminary efficacy of mechanical gait assistance combined with immersive virtual reality in patients with PD.
Patients and methods. This pilot and feasibility study followed a pre-post study design. The intervention consisted of 12 sessions of 30 minutes, distributed regularly over four consecutive weeks. Participants walked on a treadmill with a body- weight support system set at approximately 20% of body weight and equipped with a virtual reality helmet controlled by a two-handed joystick. Feasibility and intervention outcomes were collected at baseline and after four weeks of intervention.
Results. Twelve participants of 60 patients were finally enrolled. Nine of them (75%) completed the treatment intervention with an adherence rate of 97%. Two participants left the study, one of them due to sickness associated with virtual reality and another because of a lack of motivation. There were significant differences associated with small-medium effect sizes when comparing the pre and post values for walk distance, walk speed, balance, and quality of life.
Conclusions. The present study provided preliminary evidence supporting the feasibility of the combination of antigravity treadmill and immersive virtual reality system for the rehabilitation of patients with PD.

Idioma: Inglés

DOI: 10.33588/rn.7112.2020352

Año: 2020

Publicado en: Revista de neurologia 71, 12 (2020), 447-454
ISSN: 0210-0010

Factor impacto JCR: 0.87 (2020)

Categ. JCR: CLINICAL NEUROLOGY rank: 203 / 208 = 0.976 (2020) - Q4 - T3

Factor impacto SCIMAGO: 0.248 - Neurology (clinical) (Q3) - Medicine (miscellaneous) (Q3)

Financiación: info:eu-repo/grantAgreement/ES/FPI/CPB09-2018
Financiación: info:eu-repo/grantAgreement/EC/H2020/731391/EU/Collaboration among Aerospace, Biotechnology, ICT, Energy and Medical Devices sectors in generating innovative solutions, business models and work-flows that enhance patient-centered care/Cross4Health

Tipo y forma: Article (Published version)

Área (Departamento): Área Fisioterapia (Dpto. Fisiatría y Enfermería)